February 4, 2025 - 19:03

Barclays has successfully finalized the sale of its German consumer finance business, marking a significant strategic shift for the banking giant. The transaction involved the transfer of specific assets and liabilities, executed at a modest premium to the tangible book value. This move reflects Barclays' ongoing efforts to streamline its operations and focus on core markets.
The decision to divest the German consumer finance division aligns with the bank's strategy to enhance efficiency and optimize its portfolio. By shedding non-core assets, Barclays aims to strengthen its financial position and concentrate resources on more lucrative areas of its business.
The sale is expected to have a positive impact on Barclays' overall financial health, allowing the bank to allocate capital more effectively. This strategic maneuver is part of a broader trend within the banking industry, where institutions are increasingly looking to divest non-essential operations to better position themselves in a competitive market.
August 27, 2026 - 09:43
EverGen Infrastructure Reports Q2 2026 ResultsVANCOUVER - EverGen Infrastructure Corp. has released its financial results for the second quarter of 2026, covering the period ending June 30. The company, which focuses on renewable natural gas...
August 26, 2026 - 19:01
Nutanix Reports Fourth Quarter and Fiscal 2026 Financial ResultsNutanix has reported financial results for its fourth quarter and full fiscal year ending July 31, 2026, highlighting a 16 percent year-over-year increase in annual recurring revenue (ARR). The...
August 26, 2026 - 03:06
The multiplying risks of financing data centresWall Street`s biggest financial institutions are diving headfirst into the data center gold rush, but the euphoria is starting to meet a wall of caution. As the demand for artificial intelligence...
August 25, 2026 - 23:39
Akin, an Elite Global Law FirmDallas - Akin, a global law firm, recently provided legal counsel to Crestline Direct Finance, L.P. in connection with a $50 million senior secured credit facility extended to Kreg Therapeutics LLC...